150 related articles for article (PubMed ID: 3053751)
1. Thyroid volume and serum thyroglobulin levels in patients with acromegaly: correlation with plasma insulin-like growth factor I levels.
Miyakawa M; Saji M; Tsushima T; Wakai K; Shizume K
J Clin Endocrinol Metab; 1988 Nov; 67(5):973-8. PubMed ID: 3053751
[TBL] [Abstract][Full Text] [Related]
2. Plasma insulin-like growth factor-I/somatomedin-C in acromegaly: correlation with the degree of growth hormone hypersecretion.
Barkan AL; Beitins IZ; Kelch RP
J Clin Endocrinol Metab; 1988 Jul; 67(1):69-73. PubMed ID: 2897974
[TBL] [Abstract][Full Text] [Related]
3. Goiter and impairment of thyroid function in acromegalic patients: basal evaluation and follow-up.
Cannavò S; Squadrito S; Finocchiaro MD; Curtò L; Almoto B; Vieni A; Trimarchi F
Horm Metab Res; 2000 May; 32(5):190-5. PubMed ID: 10871160
[TBL] [Abstract][Full Text] [Related]
4. Supranormal stimulation of deoxyribonucleic acid synthesis in FRTL5 cells by serum from patients with untreated acromegaly.
Misaki T; Maciel RM; Tramontano D; Moses AC; Lombardi A; Ingbar SH
J Clin Endocrinol Metab; 1988 Jun; 66(6):1227-32. PubMed ID: 3372685
[TBL] [Abstract][Full Text] [Related]
5. Characterization of serum growth hormone (GH) and insulin-like growth factor I in active acromegaly with minimal elevation of serum GH.
Daughaday WH; Starkey RH; Saltman S; Gavin JR; Mills-Dunlap B; Heath-Monnig E
J Clin Endocrinol Metab; 1987 Oct; 65(4):617-23. PubMed ID: 3654910
[TBL] [Abstract][Full Text] [Related]
6. Thyroid vascularity is increased in patients with active acromegaly.
Bogazzi F; Manetti L; Bartalena L; Gasperi M; Grasso L; Cecconi E; Rago T; Pinchera A; Martino E
Clin Endocrinol (Oxf); 2002 Jul; 57(1):65-70. PubMed ID: 12100071
[TBL] [Abstract][Full Text] [Related]
7. Prevalence of thyroid diseases in patients with acromegaly: results of an Italian multi-center study.
Gasperi M; Martino E; Manetti L; Arosio M; Porretti S; Faglia G; Mariotti S; Colao AM; Lombardi G; Baldelli R; Camanni F; Liuzzi A;
J Endocrinol Invest; 2002 Mar; 25(3):240-5. PubMed ID: 11936466
[TBL] [Abstract][Full Text] [Related]
8. [Correlation between serum thyroglobulin and thyroid stimulating hormone in populations with non-toxic goiter].
Hu FN; Jin Y; Teng WP; Yang F; Teng XC; Gao TS; Wang WB; Shi XG; Tao CM
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):936-9. PubMed ID: 12899791
[TBL] [Abstract][Full Text] [Related]
9. Relationship between somatomedin-C and growth hormone levels in acromegaly: basal and dynamic evaluation.
Oppizzi G; Petroncini MM; Dallabonzana D; Cozzi R; Verde G; Chiodini PG; Liuzzi A
J Clin Endocrinol Metab; 1986 Dec; 63(6):1348-53. PubMed ID: 2878007
[TBL] [Abstract][Full Text] [Related]
10. Molecular forms of serum insulin-like growth factor (IGF)-binding proteins in man: relationships with growth hormone and IGFs and physiological significance.
Hardouin S; Gourmelen M; Noguiez P; Seurin D; Roghani M; Le Bouc Y; Povoa G; Merimee TJ; Hossenlopp P; Binoux M
J Clin Endocrinol Metab; 1989 Dec; 69(6):1291-301. PubMed ID: 2555386
[TBL] [Abstract][Full Text] [Related]
11. Serum insulin-like growth factor-binding protein-3 levels in the diagnosis of acromegaly.
Grinspoon S; Clemmons D; Swearingen B; Klibanski A
J Clin Endocrinol Metab; 1995 Mar; 80(3):927-32. PubMed ID: 7533774
[TBL] [Abstract][Full Text] [Related]
12. The occurrence of thyroid focal lesions and a need for fine needle aspiration biopsy in patients with acromegaly due to an increased risk of thyroid cancer.
Ruchala M; Skiba A; Gurgul E; Uruski P; Wasko R; Sowinski J
Neuro Endocrinol Lett; 2009; 30(3):382-6. PubMed ID: 19855364
[TBL] [Abstract][Full Text] [Related]
13. Goiter associated with acromegaly: sonographic and scintigraphic findings of the thyroid gland.
Kasagi K; Shimatsu A; Miyamoto S; Misaki T; Sakahara H; Konishi J
Thyroid; 1999 Aug; 9(8):791-6. PubMed ID: 10482372
[TBL] [Abstract][Full Text] [Related]
14. The thyroid gland in acromegaly: an ultrasonographic study.
Cheung NW; Boyages SC
Clin Endocrinol (Oxf); 1997 May; 46(5):545-9. PubMed ID: 9231049
[TBL] [Abstract][Full Text] [Related]
15. Dose-response study and long term effect of the somatostatin analog octreotide in patients with therapy-resistant acromegaly.
Quabbe HJ; Plöckinger U
J Clin Endocrinol Metab; 1989 May; 68(5):873-81. PubMed ID: 2565912
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay of a 26,000-dalton plasma insulin-like growth factor-binding protein: control by nutritional variables.
Busby WH; Snyder DK; Clemmons DR
J Clin Endocrinol Metab; 1988 Dec; 67(6):1225-30. PubMed ID: 2461386
[TBL] [Abstract][Full Text] [Related]
17. Octreotide as primary therapy for acromegaly.
Newman CB; Melmed S; George A; Torigian D; Duhaney M; Snyder P; Young W; Klibanski A; Molitch ME; Gagel R; Sheeler L; Cook D; Malarkey W; Jackson I; Vance ML; Barkan A; Frohman L; Kleinberg DL
J Clin Endocrinol Metab; 1998 Sep; 83(9):3034-40. PubMed ID: 9745397
[TBL] [Abstract][Full Text] [Related]
18. Pituitary irradiation is ineffective in normalizing plasma insulin-like growth factor I in patients with acromegaly.
Barkan AL; Halasz I; Dornfeld KJ; Jaffe CA; Friberg RD; Chandler WF; Sandler HM
J Clin Endocrinol Metab; 1997 Oct; 82(10):3187-91. PubMed ID: 9329336
[TBL] [Abstract][Full Text] [Related]
19. Value of growth hormone dynamics and somatomedin C (insulin-like growth factor I) levels in predicting the long-term benefit after transsphenoidal surgery for acromegaly.
Arafah BM; Rosenzweig JL; Fenstermaker R; Salazar R; McBride CE; Selman W
J Lab Clin Med; 1987 Mar; 109(3):346-54. PubMed ID: 3102658
[TBL] [Abstract][Full Text] [Related]
20. [Behavior of the pituitary-thyroid axis in acromegalic subjects during prolonged intermittent and pulsatile treatment with octreotide].
Cuttica CM; Fazzuoli L; Cariola G; Carraro A; Porcella E; Giusti M; Giordano G
Recenti Prog Med; 1994 Jan; 85(1):7-12. PubMed ID: 8184183
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
